FLAGSTAFF, W. L. Gore & Associates, Inc. (Gore) today announced that the Food and Drug Administration (FDA) has consented to the initiation of the clinical study for the new GORE® EXCLUDER® ...
FLAGSTAFF, Ariz., W. L. Gore & Associates, Inc. (Gore) today announced the Health Canada approval of the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE), making it the most recent off-the-shelf ...
Gore & Associates G.K. in Minato-ku, Tokyo, Japan, announced the first clinical use in Japan of the Gore Excluder thoracoa ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced that more than 250,000 patients have been treated* with the GORE® EXCLUDER® AAA Endoprosthesis. The GORE ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced receipt of CE Mark for the GORE® EXCLUDER® Conformable AAA Device, a product designed for the treatment of ...
W. L. Gore & Associates has announced it has received FDA approval for new endoprosthesis components, according to a news release. The components are a new large diameter 35 mm trunk-ipsilateral leg ...
W.L. Gore & Associates has won new technology status from the Centers for Medicare and Medicaid Services and the associated add-on reimbursement for its Excluder iliac branch endoprosthesis (IBE).
Conglomerate W.L. Gore & Associates announced FDA approval of its Excluder Iliac Branch Endoprosthesis for the treatment of common iliac artery aneurysms or aortoiliac aneurysms. The device is used in ...
W. L. Gore & Associates, Inc. (Gore) today announced the 20 th anniversary of the first implant of the GORE ® EXCLUDER ® AAA Endoprosthesis, the most-studied** endovascular aneurysm repair (EVAR) ...
due to the inability to preserve internal iliac arteries. This is excellent news for Japanese patients.” The IBE system provides a treatment range of 6.5-13.5 mm for the internal iliac arteries, and a ...
W. L. Gore & Associates, Inc. (Gore) today announced that the Food and Drug Administration (FDA) has consented to the initiation of the clinical study for the new GORE® EXCLUDER® Conformable AAA ...